Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 49

Results For "PPL"

3718 News Found

HyugaLife raises Rs 100 crore in Series A to boost AI personalisation and offline expansion
Digitisation | April 28, 2026

HyugaLife raises Rs 100 crore in Series A to boost AI personalisation and offline expansion

The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence


Ahmedabad hosts national conclave on urban pest and vector control strategies
Policy | April 28, 2026

Ahmedabad hosts national conclave on urban pest and vector control strategies

Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities


Essilor Stellest lens positioned as key breakthrough in myopia control in India
News | April 28, 2026

Essilor Stellest lens positioned as key breakthrough in myopia control in India

The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025


Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D
People | April 27, 2026

Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D

His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research


Wellness travel is moving closer to home: What’s driving the shift?
Opinion | April 27, 2026

Wellness travel is moving closer to home: What’s driving the shift?

India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle


Alembic announces FDA final approval for Fingolimod capsules
Drug Approval | April 27, 2026

Alembic announces FDA final approval for Fingolimod capsules

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis)


BMS–Pfizer expands Eliquis access through Cost Plus Drug setting $345 monthly price
Supply Chain | April 27, 2026

BMS–Pfizer expands Eliquis access through Cost Plus Drug setting $345 monthly price

The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform


Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push
Drug Approval | April 27, 2026

Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push

The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA


Huwel Lifesciences, ASMS expand into Southeast Asia with Singapore partner
Supply Chain | April 27, 2026

Huwel Lifesciences, ASMS expand into Southeast Asia with Singapore partner

Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform


NIT Rourkela secures patent for rapid spice adulteration detection system
News | April 27, 2026

NIT Rourkela secures patent for rapid spice adulteration detection system

FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants